Back to search

Article

Pluripotent stem cell-derived siTNK cells attack tumors via a synthetic CD8-CD28-TCR complex

2025-07-12

Abstract excerpt

<h4>SUMMARY</h4> Tumor-associated antigen-specific T cell receptor (TCR)-engineered T cells offer a promising strategy for cancer therapy. Natural killer (NK) cells exhibit broad anti-tumor activity with low side effects but lack the capacity to recognize intracellular antigens. Here, we found that the human pluripotent stem cell (hPSC)-derived iNK cells, unlike tissue-isolated NK cells, expressed all four CD3 su...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
043c7578-eaf0-5ac6-8f67-8c1c9492b622
DOI
10.1101/2025.07.11.663392
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Pluripotent stem cell-derived siTNK cells attack tumors via a synthetic CD8-CD28-TCR complexDOI 10.1101/2025.07.11.663392
Select a neighboring publication to make it the new centre.